[Consensus conference: Preventing the risk of Aspergillus infection in immunocompromised patients].
D000391:Air Microbiology; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications / Q000517:prevention & control*; D005374:Filtration / Q000379:methods; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D009503:Neutropenia / Q000150:complications; D016377:Organ Transplantation; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D018571:Sentinel Surveillance
D000935:Antifungal Agents; D006133:Growth Substances